Exploring the Potential of Biotech Markets

Image 4

Table of Contents

  1. Largest Biotech Companies in 2023
  2. Exploring Biotech Companies in 2023
  3. How to access stocks?
  4. Potential Benefits of Biotech Companies
  5. Risks of Biotech Stocks
  6. Conclusion

If you’re considering investing in biotech stocks, it’s important to be aware of the nature of these stocks. Biotech stocks can be highly volatile, and their prices can experience significant swings based on factors such as the outcomes of FDA clinical trials and real-world applications of their treatments.

The biotech sector may offer exciting opportunities for investors, especially considering the advancements in scientific research and the development of breakthrough drugs to treat and prevent diseases. Many top biotech companies have strong drug pipelines and already successful products on the market. 

Furthermore, the COVID-19 pandemic has created significant opportunities for biotech companies involved in the development of treatments and vaccines for the virus Whether you possess extensive investment experience or are embarking on your investment journey, continue reading to explore the foremost biotech stocks

Explore Biotech stocks on Public

Build & diversify your portfolio with banking companies across the industry

Sign Up Now

Largest Biotech Companies in 2023

TickerCompany NamePriceDividendMarket Cap
GILDGilead Sciences$3.003$95.87B
VRTXVertex Pharmaceuticals$354.05N/A$91.19B
IQVIQVIA Holdings$226.15N/A$41.96B
BNTXBioNTech SE$107.421.5498$25.89B
CRSPCrispr Therapeutics AG$56.89N/A$4.74B
NTLAIntellia Therapeutics Inc$42.36N/A$3.73B
AXSMAxsome Therapeutics Inc$78.68N/A$3.43B

Source: Xignite

*All stocks and price information in the chart presented above is as of July 31, 2023 and shows the list of companies with a market cap of over 1B, their dividend and their current price as of July 31, 2023. This chart is provided solely for informational purposes and should not be considered investment advice.

Explore Biotech stocks on Public

Build & diversify your portfolio with banking companies across the industry

Sign Up Now

Exploring Biotech Companies in 2023

Biotech companies, including pharmaceutical and biotechnology firms, are at the forefront of developing groundbreaking treatments for a range of diseases. They often utilize cutting-edge research, proprietary technology, and advancements in gene therapy to address critical healthcare challenges. From genetic diseases and autoimmune diseases to cardiovascular diseases and cancer treatments, these companies play a pivotal role in advancing medical breakthroughs.

The biotech sector may have the potential to offer significant market opportunities driven by the growing demand for innovative therapies. With the increasing prevalence of infectious diseases such as sickle cell disease, cystic fibrosis, and Type-1 Diabetes, there is a pressing need for effective treatments.

Moreover, biotech companies are leveraging technological advancements, particularly artificial intelligence (AI) and advanced technologies, to revolutionize drug discovery and development. AI-powered algorithms can swiftly analyze vast amounts of data, expediting the identification of promising drug candidates and enhancing the efficiency of clinical trials. This integration of AI in biotech research and development presents enticing opportunities for investors who recognize the potential at the intersection of technology and healthcare.

Over the years, the biotech sector has witnessed remarkable growth in market capitalization. The successful launch of innovative therapies and the anticipation of future breakthroughs have drawn the attention of investors. Biotech stocks may provide individuals with an opportunity to participate in the dynamic biotech industry and potentially benefit from its growth and significant discoveries.

How to access stocks?

  1. Create a commission - free brokerage account

    Before you open a commission free brokerage account, it’s best to research and compare your options. It’s free to join Public, and unlike other brokerages, we don’t participate in payment for order flow (PFOF)—which means we don’t sell your trades to market makers or third parties. Instead, we route all orders directly to the exchanges and other execution venues.

  2. Fund your account

    There are many ways to fund a brokerage account, most commonly by linking a bank account to deposit and withdraw settled cash. You can also use a debit card or wire transfer to fund your account. At Public, we have partnered with Plaid, the nation’s largest bank connection provider, to make funding your account easy. You also have the option to set up recurring deposts and make investing even more of a routine.

  3. Explore Stocks

    Before investing in any stock, it’s important to consider factors such as the financial health of the company, regulatory environment, market trends, and overall economic conditions.

    You can find this information on the company’s website or on financial news websites. Alternatively, you can use Public Premium, which offers company-specific insights and metrics from leading analysts

  4. Make an investment

    Once you’ve determined your investment candidates, if you are using Public, simply tap the assets and choose how much you’d like to buy. Public offers fractional investing, so you can invest in stocks and ETFs with any dollar amount.

  5. Create your own theme focused strategy with Investment Plans

    On Public, you can automate your investing strategy with a self-created Investment Plan to consistently purchase additional shares on a recurring basis. Add up to 20 stocks or ETFs to your self-created Plan, and decide how much and how often you want to invest in your plan. Build your portfolio with daily, weekly, biweekly, or monthly contributions, and choose whether you’d prefer to evenly distribute funds, or create a custom allocation that supports your investing strategy.

    If you need help narrowing down your selection, we’re soon launching pre-created Investment Plans that may allow you to gain exposure to a mix of stocks and ETFs for a certain theme.

Explore Biotech stocks on Public

Build & diversify your portfolio with banking companies across the industry

Sign Up Now

Potential Benefits of Biotech Companies

  1. Potential for Favorable Returns: The biotech industry is renowned for its ability to develop pioneering treatments, therapies, and medical breakthroughs that can revolutionize healthcare. Successful biotech companies often experience substantial growth, which can lead to attractive returns for investors, though it is far from guaranteed and comes with substantial risk.

  2. Contribution to Healthcare Innovation: Biotech companies actively drive innovation and technological advancements in the healthcare sector. They are involved in the creation of new drugs, therapies, diagnostic tools, and medical devices that have the potential to transform patient care. Investing in biotech stocks enables individuals to support and benefit from these cutting-edge developments.

  3. Opportunities for Long-Term Growth: The need for novel therapies and advancements in personalized medicine is projected to increase over time. Biotech stocks might enable individuals to participate in this long-term growth potential and potentially benefit from the rising value of these companies, though it comes with substantial risk.

Risks of Biotech Stocks

  1. Regulatory and Clinical Challenges: Biotech companies face stringent regulatory processes and clinical trials for their products. Delays in obtaining regulatory approvals or negative outcomes in clinical trials can significantly impact the financial performance of these companies. Changes in regulations or unexpected regulatory hurdles can create uncertainty and hinder the progress of biotech stocks.

  2. High Failure Rate of Drug Candidates: The development of new drugs and therapies is a complex and risky process. Biotech & pharmaceutical companies face a high failure rate in clinical trials, with many drug candidates not successfully reaching approval or commercialization stages. Failed trials can result in substantial financial losses and negatively impact the stock prices of biotech companies.

  3. Capital Intensive Nature of the Industry: The biotech industry requires significant capital investments for research, clinical trials, and manufacturing facilities. Biotech companies often operate with negative cash flows and rely on external funding sources, such as equity offerings or partnerships, to support their operations. The need for continuous financing and the potential for dilution of shareholder value can pose challenges for investors.

Explore Biotech stocks on Public

Build & diversify your portfolio with banking companies across the industry

Sign Up Now


In summary, investing in biotech stocks carries both advantages and risks. It is crucial for investors to approach biotech stock investments with a balanced perspective, considering the potential benefits and risks within the broader context of their investment portfolio and financial goals.

Furthermore, investors should conduct diligent research and analysis to gain a comprehensive understanding of the specific types and companies within the biotech sector. This approach will help investors make informed decisions based on their individual circumstances and goals, hopefully reducing the potential pitfalls associated with investing in biotech stocks.

At Public, we believe that investing should be accessible and easy for everyone. That’s why we offer a user-friendly platform that allows you to buy and sell stocks, ETFs, Treasuries, crypto, and alternative assets—all in one place. Sign up today and continue your journey toward financial freedom.

Banner Learn Desktop